Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127018411 | 12701841 | 1 | I | 20160418 | 0 | 20160830 | 20160830 | DIR | 49.71 | YR | F | N | 68.10000 | KG | 20160822 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127018411 | 12701841 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | 0 | 340 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127018411 | 12701841 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127018411 | 12701841 | Blood pressure increased | |
| 127018411 | 12701841 | Blood pressure measurement | |
| 127018411 | 12701841 | Dysarthria | |
| 127018411 | 12701841 | Facial paralysis | |
| 127018411 | 12701841 | Headache | |
| 127018411 | 12701841 | Mass | |
| 127018411 | 12701841 | Platelet count decreased | |
| 127018411 | 12701841 | Seizure | |
| 127018411 | 12701841 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127018411 | 12701841 | 1 | 20160325 | 0 |